aod9604 weight loss evidence clinical trials AOD-9604 Peptide AOD-9604 Clinical Trial Results &

Call Today for Your Free Consultation If you have more questions about any of our weight loss options or are ready to begin your weight loss journey, call today and schedule a free consultation

Which Option Is Right for You

By keeping your details up to date, you can continue to enjoy fast and reliable service

Because neither compound is licensed in the UK, no formal pharmacokinetic or pharmacodynamic interaction studies have been conducted or reviewed by the MHRA

Switching is possible but not straightforward

Standard Dosing Schedule Most research and practical application suggests the following framework for 5-Amino-1MQ capsules or injectable forms: Beginner Protocol: Dose: 50-100 mg daily Timing: Morning (6-8 AM), fasted state Duration: 8 weeks initial cycle Assessment: Monitor weekly for response Intermediate Protocol: Dose: 100-200 mg daily Timing: Morning administration or split dose Duration: 8-12 weeks per cycle Cycling: 4-6 weeks off between cycles Advanced Protocol: Dose: 200-300 mg daily (under professional guidance) Timing: Split dosing (morning/afternoon) Duration: 12 weeks maximum per cycle Integration: Coordinated with other peptides or protocols Cycling Strategy for Long-Term Success Cycling prevents receptor downregulation and maintains effectiveness over time